Pulmonology Advisor

Multidrug-resistant TB outcomes with pyrazinamide susceptibility testing

Introducing pyrazinamide molecular susceptibility testing in the treatment of multidrug-resistant tuberculosis improved outcomes without the use of new drugs and shortened the World Health Organization (WHO) 20+ month regimen to 12 months, according to a study published in the European Respiratory Journal.

Read More →

Elevated TB risk in inhaled corticosteroid users

The risk of contracting tuberculosis (TB) is greater in patients who use inhaled corticosteroids (ICSs) or who have used them in the past 3 years, and the risk is even greater in patients with chronic obstructive pulmonary disease (COPD), according to a study published in The Journal of Allergy and Clinical Immunology: In Practice

Read More →

Page 1 of 1 · Total posts: 2

1